We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership

News   May 30, 2018 | Original story from Ipsen

 
Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership

Credit: Ipsen

 
 
 

RELATED ARTICLES

Non-circulating T Cells Vital for Protection against Salmonella

News

Noncirculating T cells are relatively unknown, but appear to be a vital component of immunity to Salmonella infection — and should be the focus of vaccine strategies.

READ MORE

'Waltzing' Nanoparticles Could Lead to Better Drug Delivery

News

Indiana University researchers have discovered that drug-delivering nanoparticles attach to their targets differently based upon their position when they meet -- like ballroom dancers who change their moves with the music.

READ MORE

Stealth-cap Technology for Light-emitting Nanoparticles

News

A team of scientists from the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), in collaboration with researchers from Monash University Australia, has succeeded in significantly increasing the stability and biocompatibility of special light-transducing nanoparticles.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE